AKBA · Akebia Therapeutics, Inc.

$0.90 -0.05 (-5.45%)

Market Cap

$264.47M

277.11M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Butler	CEO	$864,010	—	$2,164,338	$2,024,798	$580,973	$18,220	$5,652,339
Steven Burke	Chief Medical Officer	$600,538	—	$436,576	$562,915	$242,286	$17,500	$1,859,815
Erik Ostrowski	CFO	$552,919	—	$436,576	$562,915	$223,074	$16,877	$1,792,361
Nicholas Grund	Chief Commercial Officer	$506,742	—	$436,576	$562,915	$204,672	$17,500	$1,728,405

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Butler	CEO	$833,966	—	$1,013,880	$1,314,898	$1,033,200	$64,170	$4,260,114
Nicholas Grund	Chief Commercial Officer	$459,393	—	$509,544	$660,863	$206,384	$18,447	$1,854,631
Steven Burke	Chief Medical Officer	$579,653	—	$339,696	$440,575	$433,853	$17,250	$1,811,027
Erik Ostrowski	CFO	$284,414	—	$357,000	$445,310	$127,825	$573	$1,215,122
Michel Dahan	COO	$251,850	—	$250,824	$325,383	$75,000	$309,406	$1,212,463
Ellen Snow	CFO	$99,641	—	$250,824	$325,383	—	$372,773	$1,048,621

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Butler	CEO	$795,723	—	$184,669	$780,318	$997,193	$17,220	$2,775,123
Ellen Snow	CFO	$216,346	—	$617,900	$786,596	$85,438	$9,534	$1,715,814
Michel Dahan	COO	$505,488	—	$226,000	—	$499,036	$14,850	$1,245,374
Steven Burke	Chief Medical Officer	$553,104	—	$123,606	$152,053	$367,785	$16,500	$1,213,048
Nicole R. Hadas	Senior Vice President, Chief Legal Officer and Corporate Secretary	$477,908	—	$113,000	—	$438,176	$17,220	$1,046,304
David A. Spellman	CFO	$254,759	—	$123,606	$152,053	$125,000	$287,209	$942,627

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Butler	CEO	$765,118	—	$633,150	$1,116,177	$542,277	$15,816	$3,072,538
David A. Spellman	CFO	$504,666	$100,000	$218,620	$405,295	$339,609	$17,650	$1,585,841
Steven Burke	Chief Medical Officer	$526,766	—	$212,160	$399,823	$224,007	$15,801	$1,378,557
Michel Dahan	COO	$505,488	—	$190,560	$362,099	$214,959	$14,279	$1,287,386
Nicole R. Hadas	Senior Vice President, Chief Legal Officer and Corporate Secretary	$468,351	—	$190,560	$362,099	$203,230	$15,798	$1,240,038

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Butler	CEO	$718,430	$75,000	$821,404	$951,272	$552,256	$14,954	$3,133,316
David A. Spellman	CFO	$473,871	$75,000	$242,200	$688,739	$234,170	$7,496	$1,721,477
Steven Burke	Chief Medical Officer	$494,623	$75,000	$242,200	$282,836	$244,424	$7,489	$1,346,572
Michel Dahan	COO	$474,643	$75,000	$214,520	$259,266	$234,551	$9,990	$1,267,970
Nicole R. Hadas	Senior Vice President, Chief Legal Officer and Corporate Secretary	$448,747	$75,000	$214,520	$259,266	$221,754	$11,166	$1,230,453

Executive changes

Person	Role	Change	Effective	Filed
Philip J. Vickers, Ph.D.	Class I director	Appointed	2026-04-01	2026-04-01
Myles Wolf, M.D., M.M.Sc.	Class II director	Appointed	2025-06-10	2025-06-13
John P. Butler	Class II director	Appointed	2025-06-10	2025-06-13
Erik Ostrowski	Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer and principal financial officer	Appointed	2024-06-24	2024-06-24
John Butler	interim principal financial officer	Appointed	2024-03-22	2024-03-15
Richard C. Malabre	Chief Accounting Officer and principal accounting officer	Appointed	2024-01-08	2024-01-08

Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 53 filings 53 filers Visit website Investor relations